Inactive Instrument

Pfizer Inc Share Price Nyse

Equities

Pharmaceuticals

End-of-day quote Nyse
- USD - Intraday chart for Pfizer Inc
Sales 2024 * 59.96B 5,003B Sales 2025 * 62.57B 5,221B Capitalization 145B 12,116B
Net income 2024 * 6.75B 563B Net income 2025 * 9.29B 775B EV / Sales 2024 * 3.21 x
Net Debt 2024 * 47.04B 3,925B Net Debt 2025 * 41.91B 3,497B EV / Sales 2025 * 2.99 x
P/E ratio 2024 *
18.8 x
P/E ratio 2025 *
13.7 x
Employees -
Yield 2024 *
6.61%
Yield 2025 *
6.78%
Free-Float 59.09%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 62 01/93/01
Director of Finance/CFO 59 02/22/02
Chief Tech/Sci/R&D Officer - 01/19/01
Members of the board TitleAgeSince
Director/Board Member 66 01/20/01
Director/Board Member 64 23/17/23
Director/Board Member 60 27/13/27
More insiders
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company